Literature DB >> 24917759

Significance of random bladder biopsies in non-muscle invasive bladder cancer.

Masafumi Kumano1, Hideaki Miyake1, Yuzo Nakano1, Masato Fujisawa1.   

Abstract

BACKGROUND/AIMS: To evaluate retrospectively the clinical outcome of random bladder biopsies in patients with non-muscle invasive bladder cancer (NMIBC) undergoing transurethral resection (TUR). PATIENTS AND
METHOD: This study included 234 consecutive patients with NMIBC who underwent random biopsies from normal-appearing urothelium of the bladder, including the anterior wall, posterior wall, right wall, left wall, dome, trigone and/or prostatic urethra, during TUR. RESULT: Thirty-seven patients (15.8%) were diagnosed by random biopsies as having urothelial cancer. Among several factors available prior to TUR, preoperative urinary cytology appeared to be independently related to the detection of urothelial cancer in random biopsies on multivariate analysis. Urinary cytology prior to TUR gave 50.0% sensitivity, 91.7% specificity, 56.8% positive predictive value and 89.3% negative predictive value for predicting the findings of the random biopsies.
CONCLUSION: Biopsies of normal-appearing urothelium resulted in the additional detection of urothelial cancer in a definite proportion of NMIBC patients, and it remains difficult to find a reliable alternative to random biopsies. Collectively, these findings suggest that it would be beneficial to perform random biopsies as part of the routine management of NMIBC.

Entities:  

Keywords:  Non-muscle invasive bladder cancer; Random biopsy; Urinary cytology

Year:  2013        PMID: 24917759      PMCID: PMC4017739          DOI: 10.1159/000356249

Source DB:  PubMed          Journal:  Curr Urol        ISSN: 1661-7649


  14 in total

Review 1.  A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group.

Authors:  Maurizio Brausi; J Alfred Witjes; Donald Lamm; Raj Persad; Joan Palou; Marc Colombel; Roger Buckley; Mark Soloway; Hideyuki Akaza; Andreas Böhle
Journal:  J Urol       Date:  2011-10-19       Impact factor: 7.450

Review 2.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.

Authors:  Marko Babjuk; Willem Oosterlinck; Richard Sylvester; Eero Kaasinen; Andreas Böhle; Juan Palou-Redorta; Morgan Rouprêt
Journal:  Eur Urol       Date:  2011-03-22       Impact factor: 20.096

3.  Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee.

Authors:  A van der Meijden; W Oosterlinck; M Brausi; K H Kurth; R Sylvester; C de Balincourt
Journal:  Eur Urol       Date:  1999-04       Impact factor: 20.096

4.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

Authors:  Richard J Sylvester; Adrian P M van der Meijden; Willem Oosterlinck; J Alfred Witjes; Christian Bouffioux; Louis Denis; Donald W W Newling; Karlheinz Kurth
Journal:  Eur Urol       Date:  2006-01-17       Impact factor: 20.096

Review 5.  Multivariate analysis of the prognostic factors of primary superficial bladder cancer.

Authors:  F Millán-Rodríguez; G Chéchile-Toniolo; J Salvador-Bayarri; J Palou; J Vicente-Rodríguez
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

6.  A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.

Authors:  Yves Fradet; H Barton Grossman; Leonard Gomella; Seth Lerner; Michael Cookson; David Albala; Michael J Droller
Journal:  J Urol       Date:  2007-05-11       Impact factor: 7.450

Review 7.  Management of non-muscle-invasive (superficial) bladder cancer.

Authors:  Vinod H Nargund; C K Tanabalan; M N Kabir
Journal:  Semin Oncol       Date:  2012-10       Impact factor: 4.929

8.  Multiple biopsies of normal-looking urothelium in patients with superficial bladder cancer: Are they necessary?

Authors:  Naohiro Fujimoto; Shuji Harada; Michikazu Terado; Hideki Sato; Tetsuro Matsumoto
Journal:  Int J Urol       Date:  2003-12       Impact factor: 3.369

9.  Value of random mucosal biopsies in the management of superficial bladder cancer.

Authors:  G R Mufti; M Singh
Journal:  Eur Urol       Date:  1992       Impact factor: 20.096

10.  Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urological Group.

Authors:  L A Kiemeney; J A Witjes; R P Heijbroek; N P Koper; A L Verbeek; F M Debruyne
Journal:  Br J Urol       Date:  1994-02
View more
  2 in total

1.  Significance of 5-Aminolevulinic Acid-mediated Photodynamic Diagnosis Following Standard Transurethral Resection in Non-muscle Invasive Bladder Cancer.

Authors:  Kyohei Watanabe; Keita Tamura; Yuto Matsushita; Hiromitsu Watanabe; Daisuke Motoyama; Toshiki Ito; Takayuki Sugiyama; Atsushi Otsuka; Hideaki Miyake
Journal:  Cancer Diagn Progn       Date:  2021-07-03

Review 2.  Are we closer to seeing carcinoma in situ in the upper urinary tract?

Authors:  Sławomir G Kata; Omar Aboumarzouk
Journal:  Cent European J Urol       Date:  2016-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.